Related references
Note: Only part of the references are listed.Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
Akira Sezai et al.
CIRCULATION JOURNAL (2013)
Changes in serum uric acid have a reciprocal effect on eGFR change: a 10-year follow-up study of community-based screening in Okinawa, Japan
Kunitoshi Iseki et al.
HYPERTENSION RESEARCH (2013)
Increased Uric Acid Promotes Decline of the Renal Function in Hypertensive Patients: A 10-year Observational Study
Yuko Ohta et al.
INTERNAL MEDICINE (2013)
Association Between Adverse Reactions to Allopurinol and Exposures to High Maintenance Doses Implications for Management of Patients Using Allopurinol
Tawatchai Paisansinsup et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2013)
Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease
S. Kobayashi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress
Hidetoshi Tsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy
Hiroki Omori et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Association of Hyperuricemia with Renal Outcomes, Cardiovascular Disease, and Mortality
Wan-Chun Liu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review
Rodolfo V. Curiel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
A Repeated Oral Administration Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Impaired Renal Function in Japan
Hosoya Tatsuo et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Renal Function in Gout Long-Term Treatment Effects of Febuxostat
Andrew Whelton et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Metabolism and Excretion of [14C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male Subjects
Brian A. Grabowski et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Challenges of conducting a trial of uric-acid-lowering therapy in CKD
Sunil V. Badve et al.
NATURE REVIEWS NEPHROLOGY (2011)
Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: A questionnaire survey
Izaya Nakaya et al.
NEPHROLOGY (2011)
JAPANESE GUIDELINE FOR THE MANAGEMENT OF HYPERURICEMIA AND GOUT: SECOND EDITION
Hisashi Yamanaka
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem
Duk-Hee Kang et al.
SEMINARS IN NEPHROLOGY (2011)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial
Daniel I. Feig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
K Iseki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects
K Iseki et al.
HYPERTENSION RESEARCH (2001)
Share Paper
